Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
US7763623B2 · kind B2 · utility
8Cited by
2References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 17, 2007 |
| Grant date | Jul 27, 2010 |
| Priority date | — |
| Expiry date | Feb 16, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound having the general structure of Formula (I):or a pharmaceutically acceptable salt, solvate, ester, or tautomer thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome and dyslipidemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.